Seanko
Well-Known Member
The ME Association is funding new study into mitochondria a& ME/CFS. The award has been Dr Karl Morten and Professor Joanna Poulton at the University of Oxford.
http://www.meassociation.org.uk/201...e-of-the-mitochondria-in-mecfs-10-march-2016/
[bimg=300|no-lightbox]https://pbs.twimg.com/media/CdLcrzJUMAAKaye.jpg[/bimg]
ME Association to fund fourth study into the role of the mitochondria in ME/CFS
Is aberrant mitochondrial function a major player in CFS/ME?
Mitochondria are well known for their role as the ‘power house of the cell’. But they also have a diverse range of other functions.
These include a role in programming cell death, synthesis of cellular building blocks, cell-signalling and more recently a potential role in cellular immunity (West et al 2015).
Control of mitochondrial number, quality and structure is a highly regulated process varying between cells and tissues.
The fatigue seen in CFS/ME patients and the post-exertional malaise observed in the majority of patients has led to the proposal that a failure in the energy generation/supply system at a cellular level may play a role in the disease.
MEA project grant (5 months):
Establishing protocols to assess mitochondrial function in Neutrophils and Monocytes from ME/CFS patients.
The current pilot study is to set up the tests required to assess mitochondrial function in blood samples from ME/CFS patients.
For this we will use cell models with known mitochondrial dysfunction and bio-energetic impairment to both validate and improve on the tests developed by Acumen [2-4].
Our goal is to develop a method to assess mitochondrial function compatible with the widely used Seahorse Biosciences metabolic flux analyzer and plate based fluorescent probe oxygen and pH measuring platforms.
This will make the blood tests more globally accessible to a wide range of researchers allowing a more universal validation of the findings of Booth/Myhill.
Easy-to-understand information on mitochondria and mitochondrial disease:
www.mitoaction.org/mito-faq
http://www.meassociation.org.uk/201...e-of-the-mitochondria-in-mecfs-10-march-2016/
[bimg=300|no-lightbox]https://pbs.twimg.com/media/CdLcrzJUMAAKaye.jpg[/bimg]
ME Association to fund fourth study into the role of the mitochondria in ME/CFS
Is aberrant mitochondrial function a major player in CFS/ME?
Mitochondria are well known for their role as the ‘power house of the cell’. But they also have a diverse range of other functions.
These include a role in programming cell death, synthesis of cellular building blocks, cell-signalling and more recently a potential role in cellular immunity (West et al 2015).
Control of mitochondrial number, quality and structure is a highly regulated process varying between cells and tissues.
The fatigue seen in CFS/ME patients and the post-exertional malaise observed in the majority of patients has led to the proposal that a failure in the energy generation/supply system at a cellular level may play a role in the disease.
MEA project grant (5 months):
Establishing protocols to assess mitochondrial function in Neutrophils and Monocytes from ME/CFS patients.
The current pilot study is to set up the tests required to assess mitochondrial function in blood samples from ME/CFS patients.
For this we will use cell models with known mitochondrial dysfunction and bio-energetic impairment to both validate and improve on the tests developed by Acumen [2-4].
Our goal is to develop a method to assess mitochondrial function compatible with the widely used Seahorse Biosciences metabolic flux analyzer and plate based fluorescent probe oxygen and pH measuring platforms.
This will make the blood tests more globally accessible to a wide range of researchers allowing a more universal validation of the findings of Booth/Myhill.
Easy-to-understand information on mitochondria and mitochondrial disease:
www.mitoaction.org/mito-faq